Latest big gains, page 2
-
GeneDx rose 135-fold on genome tests, then lost 66% on pay fears
GeneDx rose from $1.24 in 2023 to $167 by betting on rare-disease DNA tests, then lost about two-thirds as payments per test fell short.
GeneDx rose from $1.24 in 2023 to $167 by betting on rare-disease DNA tests, then lost about two-thirds as payments per test fell short.